Skip to main content
Abbott India Ltd. logo

Abbott India Ltd. — Investor Relations & Filings

Ticker · ABBOTINDIA ISIN · INE358A01014 LEI · 5493008KZ9E3HFRN6T46 BSE.NS Manufacturing
Filings indexed 448 across all filing types
Latest filing 2020-09-07 Regulatory Filings
Country IN India
Listing BSE.NS ABBOTINDIA

About Abbott India Ltd.

https://www.abbott.co.in

Abbott India Ltd. is a pharmaceutical entity focused on providing high-quality healthcare solutions through a diverse portfolio of trusted brands. The company specializes in several key therapeutic areas, including women's health, gastroenterology, cardiology, metabolic disorders, primary care, and the central nervous system. Its product range features well-known formulations such as Duphaston, Thyronorm, Udiliv, Vertin, and Digene. The organization leverages advanced manufacturing capabilities and an extensive distribution network to serve healthcare professionals and patients. It emphasizes science-based innovation and clinical excellence to address evolving medical needs. By maintaining a strong focus on patient outcomes and therapeutic efficacy, the company has established itself as a reliable provider of pharmaceutical products across various specialized and general medical segments.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith the Results of ....
Regulatory Filings
2020-09-07 English
This is to inform you that the Seventy-sixth Annual General Meeting ('AGM') of the Company is scheduled to be held on Monday, September 7, 2020 at 9:00 a.m. (IST) through Video-Conferencing ....
Annual Report Classification · 100% confidence The document is a letter dated August 16, 2020, from Abbott India Limited addressed to BSE Limited, submitting the Annual Report for the year ended March 31, 2020, as per SEBI regulations. It mentions the 76th Annual General Meeting scheduled for September 7, 2020, and encloses the Annual Report including the Notice of AGM, Standalone Financial Statements, Board's Report, and Auditors' Report. The document contains detailed corporate overview, financial highlights, management messages, statutory reports, and financial statements. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content and structure clearly identify it as the company's official Annual Report for fiscal year 2019-20.
2020-08-16 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed the newspaper cuttings, ....
Regulatory Filings
2020-08-15 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper cuttings ....
Regulatory Filings
2020-08-09 English
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results ....
Regulatory Filings
2020-08-07 English
Pursuant to Regulation 47 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the Notices published ....
Regulatory Filings
2020-07-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.